EDIT
Editas Medicine
$2.95
+$0.35 (+13.46%)Oct 28, 2026
Key metrics
The numbers that frame EDIT today
- Market cap
- $453.06M
- Gross margin
- 100%
- EV / Sales
- 7.3
- ROIC
- -126.8%
- Div yield
- 0%
- Debt / equity
- 0.7
- 52wk Low
- $1.66
- 52wk High
- $3.94
Growth
Revenue and earnings trend for EDIT
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about EDIT
Is Editas Medicine a good buy?
No. Editas Medicine has poor quality and mixed momentum. The setup is weak overall. Growth looks weak. That could put pressure on the long-term business case. We think Editas Medicine is selling at a very high price.
What is the market capitalization of EDIT?
Editas Medicine's market capitalization is $453.06M.
What is the 52-week high for EDIT stock?
The 52-week high for Editas Medicine is $3.94. The current close of $2.95 is 25.1% below that high.
What is the 52-week low for EDIT stock?
The 52-week low for Editas Medicine is $1.66. The current close of $2.95 is 77.7% above that low.
Does EDIT stock pay dividends?
Editas Medicine does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for EDIT?
Editas Medicine's Debt / Equity ratio is 0.68.